Publications

2021

Yang Y, McCloskey JE, Yang H, Puc J, Alcaina Y, Vedvyas Y, et al. Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses. Cancer Immunol Res. 2021;9(10):1158-1174.
Luo B, Jin MM, Li X, Makunga NP, Hu X. Yeast Surface Display for Biosynthetic Pathway Reconstruction. ACS Synth Biol. 2021;10(11):2938-2946.
Cheal SM, Patel M, Yang G, Veach DR, Xu H, Guo H-, et al. Correction to An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy. Bioconjug Chem. 2021;32(2):394.
Aboushady Y, Gabr M, ElHady AK, Salah M, Abadi AH, Wilms G, et al. Discovery of Hydroxybenzothiazole Urea Compounds as Multitargeted Agents Suppressing Major Cytotoxic Mechanisms in Neurodegenerative Diseases. ACS Chem Neurosci. 2021;12(22):4302-4318.
Kelly JM, Amor-Coarasa A, Sweeney E, Wilson JJ, Causey PW, Babich JW. A suitable time point for quantifying the radiochemical purity of Ac-labeled radiopharmaceuticals. EJNMMI Radiopharm Chem. 2021;6(1):38.
Chen X, Lee SK, Song M, Zhang T, Han MS, Chen Y-, et al. RHAMM-mediated bifunctional nanotherapy targeting Bcl-xL and mitochondria for pancreatic neuroendocrine tumor treatment. Mol Ther Oncolytics. 2021;23:277-287.
Zhang W, Du B, Gao M, Tung C-. A Hybrid Nanogel to Preserve Lysosome Integrity for Fluorescence Imaging. ACS Nano. 2021;15(10):16442-16451.
Egan CE, Stefanova D, Ahmed A, Raja VJ, Thiesmeyer JW, Chen KJ, et al. CSPG4 Is a Potential Therapeutic Target in Anaplastic Thyroid Cancer. Thyroid. 2021;31(10):1481-1493.
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, et al. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjug Chem. 2021;32(4):649-654.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065